Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasandra Bélanger

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Protein Engineering, Design & Selection : PEDS|May 15, 2021
High-efficacy, high-manufacturability human VH domain antibody therapeutics from transgenic sourcesKasandra Bélanger, Jamshid Tanha
Virology|May 15, 2015
RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiencyKasandra Bélanger, Marc-André Langlois
The Journal of General Virology|June 7, 2015
Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3GKasandra Bélanger, Marc-André Langlois
The Journal of Experimental Biology|November 8, 2013
Intraspecific variation in flight metabolic rate in the bumblebee Bombus impatiens: repeatability and functional determinants in workers and dronesCharles-A Darveau, Fannie Billardon, Kasandra Bélanger
Bio-Protocol|August 16, 2021
Selective Isolation of Retroviruses from Extracellular Vesicles by Intact Virion ImmunoprecipitationTyler Milston Renner, Kasandra Bélanger, Marc-André Langlois
Frontiers in Drug Delivery|August 21, 2025
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteriaArsalan S Haqqani, Kasandra Bélanger, Danica B Stanimirovic
Bio-Protocol|August 16, 2021
Retroviral Capsid Core Stability AssayTyler Milston Renner, Kasandra Bélanger, Marc-André Langlois
The FEBS Journal|March 22, 2021
Immunogenicity and humanization of single-domain antibodiesMartin A Rossotti, Kasandra Bélanger, Kevin A Henry, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS DiseasesKasandra Bélanger, Umar Iqbal, Jamshid Tanha, et al.
Virology|June 4, 2018
Characterization of molecular attributes that influence LINE-1 restriction by all seven human APOBEC3 proteinsTyler Milston Renner, Kasandra Bélanger, Laura Rose Goodwin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Protein Engineering, Design & Selection : PEDS|May 15, 2021
High-efficacy, high-manufacturability human VH domain antibody therapeutics from transgenic sourcesKasandra Bélanger, Jamshid Tanha
Virology|May 15, 2015
RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiencyKasandra Bélanger, Marc-André Langlois
The Journal of General Virology|June 7, 2015
Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3GKasandra Bélanger, Marc-André Langlois
The Journal of Experimental Biology|November 8, 2013
Intraspecific variation in flight metabolic rate in the bumblebee Bombus impatiens: repeatability and functional determinants in workers and dronesCharles-A Darveau, Fannie Billardon, Kasandra Bélanger
Bio-Protocol|August 16, 2021
Selective Isolation of Retroviruses from Extracellular Vesicles by Intact Virion ImmunoprecipitationTyler Milston Renner, Kasandra Bélanger, Marc-André Langlois
Frontiers in Drug Delivery|August 21, 2025
Receptor-mediated transcytosis for brain delivery of therapeutics: receptor classes and criteriaArsalan S Haqqani, Kasandra Bélanger, Danica B Stanimirovic
Bio-Protocol|August 16, 2021
Retroviral Capsid Core Stability AssayTyler Milston Renner, Kasandra Bélanger, Marc-André Langlois
The FEBS Journal|March 22, 2021
Immunogenicity and humanization of single-domain antibodiesMartin A Rossotti, Kasandra Bélanger, Kevin A Henry, et al.
Antibodies (Basel, Switzerland)|September 24, 2019
Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS DiseasesKasandra Bélanger, Umar Iqbal, Jamshid Tanha, et al.
Virology|June 4, 2018
Characterization of molecular attributes that influence LINE-1 restriction by all seven human APOBEC3 proteinsTyler Milston Renner, Kasandra Bélanger, Laura Rose Goodwin, et al.
Pageof 2